psilocybin has been researched along with 2-(4-bromo-2,5-dimethoxyphenyl)-n-((2-methoxyphenyl)methyl)ethanamine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Burmester, D; Dyssegaard, A; Erritzoe, D; Fisher, PM; Johansen, SS; Knudsen, GM; Kristiansen, S; Lehel, S; Linnet, K; Madsen, MK; Ozenne, B; Stenbæk, DS; Svarer, C | 1 |
| Fisher, PM; Jensen, PS; Knudsen, GM; Kristiansen, S; Madsen, MK; McCulloch, DE; Ozenne, B; Stenbæk, DS | 1 |
2 other study(ies) available for psilocybin and 2-(4-bromo-2,5-dimethoxyphenyl)-n-((2-methoxyphenyl)methyl)ethanamine
| Article | Year |
|---|---|
Psychedelic effects of psilocybin correlate with serotonin 2A receptor occupancy and plasma psilocin levels.
Topics: Adult; Benzylamines; Brain; Carbon Radioisotopes; Female; Hallucinogens; Humans; Male; Phenethylamines; Positron-Emission Tomography; Protein Binding; Psilocybin; Receptor, Serotonin, 5-HT2A; Serotonin 5-HT2 Receptor Agonists | 2019 |
Lasting effects of a single psilocybin dose on resting-state functional connectivity in healthy individuals.
Topics: Adult; Benzylamines; Brain; Dose-Response Relationship, Drug; Executive Function; Female; Follow-Up Studies; Hallucinogens; Humans; Magnetic Resonance Imaging; Male; Neural Pathways; Phenethylamines; Positron-Emission Tomography; Psilocybin; Time Factors; Young Adult | 2022 |